Gastric Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastric Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-07-31Clinical Trial Update: Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels [Phase 2]
Phase 2 study evaluating chemotherapy with or without sequential cytoreductive surgery for metastatic foregut cancer with undetectable circu…
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: Neoadjuvant Serplulimab in Combination With Chemotherapy in Locally Advanced Gastric or Gastro-esophageal Junction Cancer [Phase 2]
This Phase 2 trial is evaluating neoadjuvant serplulimab with chemotherapy for locally advanced gastric or gastroesophageal junction cancer.…
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: Stomach Cancer Exosome-based Detection
A clinical trial evaluating an exosome-based detection method for gastric cancer has completed.
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma [Phase 2]
A Phase 2 clinical trial is evaluating FOLFIRI plus Durvalumab versus FOLFIRI plus Durvalumab and Tremelimumab as second-line treatment for …
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastrectomies for Gastric Cancer (PhotoNodes)
Clinical trial update describing a study (PhotoNodes) evaluating whether intra-operative photographs can assess the adequacy of lymphadenect…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer [Phase 2]
A Phase 2 trial is evaluating AK104 with AK112 and SOX/XELOX chemotherapy as first-line treatment for advanced gastric and gastroesophageal …
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer [Phase 2]
A Phase 2 clinical trial is evaluating whether adding Fruquintinib to Sintilimab and chemotherapy improves outcomes versus Sintilimab and ch…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma [Phase 2]
A Phase 2 trial of ramucirumab plus irinotecan in previously treated advanced gastric or gastroesophageal junction adenocarcinoma has comple…
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: Phase II Trial of Neoadjuvant Pembrolizumab for Patients With Early Stage Gastroesophageal Adenocarcinoma [Phase 2]
Phase II neoadjuvant pembrolizumab trial for early-stage gastroesophageal junction, gastric, and esophageal adenocarcinoma has been terminat…
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy [Phase 2]
Phase 2 clinical trial by Zhejiang Cancer Hospital evaluating multimodal rehabilitation for gastric cancer patients following radical D2 gas…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer [NA]
This completed clinical trial evaluated the effects of probiotic supplementation on the intestinal microbiota of patients with gastric cance…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma [Phase 3]
Clinical trial update for a Phase 3 study evaluating D2 resection with hyperthermic intraperitoneal chemoperfusion (HIPEC) in locally advanc…
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update for derazantinib alone or with paclitaxel, ramucirumab, or atezolizumab in gastric adenocarcinoma; study terminated wi…
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: First-line Apatinib Combined With Tislelizumab and Chemotherapy for Advanced GC [Phase 2]
Phase 2 trial update evaluating first-line apatinib combined with tislelizumab and chemotherapy for advanced gastric adenocarcinoma has comp…
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma [Phase 1]
Phase 1 trial updating TAS-102 combined with irinotecan in second-line or higher gastric and gastroesophageal adenocarcinoma; study complete…
-
CLINICAL_TRIALS trial_result · 2024-01-29Clinical Trial Update: Adebrelimab Combined With SOX Regimen in Preoperative Neoadjuvant Transformation Therapy for Locally Advanced Gastric Adenocarcinoma [Phase 4]
Phase 4 trial update exploring Adebrelimab combined with SOX as neoadjuvant therapy for locally advanced gastric adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma [Phase 2]
Phase 2 trial investigating Envafolimab in combination with chemotherapy for metastatic or recurrent gastric adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas [Phase 2]
Phase 2 trial of mFOLFOX6 plus trastuzumab and avelumab in gastric and esophageal adenocarcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis [Phase 2]
Phase 2 study evaluating combined intraperitoneal/intravenous paclitaxel with oral capecitabine for gastric adenocarcinoma with peritoneal c…
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: A Study of CS1001 in Subjects With Gastric Adenocarcinoma or Gastro-Esophageal Junction Adenocarcinoma [Phase 3]
Phase 3 trial update for CS1001 in gastric adenocarcinoma and gastroesophageal junction adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial evaluating perioperative leucovorin, oxaliplatin, docetaxel and S-1 (LOTS) for locally advanced gastric or gastroesop…
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859) [Phase 3]
Phase 3 trial MK-3475-859 (KEYNOTE-859) evaluating pembrolizumab plus chemotherapy versus placebo plus chemotherapy in gastric/GEJ adenocarc…
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric Cancer [Phase 2]
Phase II clinical study evaluating surufatinib in combination with sintilimab for advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma. [Phase 3]
Phase 3 trial evaluating gentuximab plus paclitaxel versus placebo plus paclitaxel in gastric adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Study of Pembrolizumab in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-Line Therapy With Platinum and Fluoropyrimidine: Integration of Molecular Subtypes Through Integrative Genomic Analysis [Phase 2]
Phase 2 trial of pembrolizumab in advanced gastric or gastroesophageal junction adenocarcinoma after progression on platinum/fluoropyrimidin…